Cargando…
Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms
BACKGROUND: Patients with SARS-CoV-2 who present with gastrointestinal symptoms have a milder clinical course than those who do not. Risk factors for severe COVID-19 disease include increased adiposity and sarcopenia. AIMS: To determine whether body composition risk factors are associated with worse...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612109/ https://www.ncbi.nlm.nih.gov/pubmed/34820728 http://dx.doi.org/10.1007/s10620-021-07324-4 |
_version_ | 1784603414042247168 |
---|---|
author | Nobel, Yael R. Su, Steven H. Anderson, Michaela R. Luk, Lyndon Small-Saunders, Jennifer L. Reyes-Soffer, Gissette Gallagher, Dympna Freedberg, Daniel E. |
author_facet | Nobel, Yael R. Su, Steven H. Anderson, Michaela R. Luk, Lyndon Small-Saunders, Jennifer L. Reyes-Soffer, Gissette Gallagher, Dympna Freedberg, Daniel E. |
author_sort | Nobel, Yael R. |
collection | PubMed |
description | BACKGROUND: Patients with SARS-CoV-2 who present with gastrointestinal symptoms have a milder clinical course than those who do not. Risk factors for severe COVID-19 disease include increased adiposity and sarcopenia. AIMS: To determine whether body composition risk factors are associated with worse outcomes among patients with gastrointestinal symptoms. METHODS: This was a retrospective study of hospitalized patients with COVID-19 who underwent abdominal CT scan for clinical indications. Abdominal body composition measures including skeletal muscle index (SMI), intramuscular adipose tissue index (IMATI), visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), visceral-to-subcutaneous adipose tissue ratio (VAT/SAT ratio), and liver and spleen attenuation were collected. The association between body composition measurements and 30-day mortality was evaluated in patients with and without gastrointestinal symptoms at the time of positive SARS-CoV-2 test. RESULTS: Abdominal CT scans of 190 patients with COVID-19 were evaluated. Gastrointestinal symptoms including nausea, vomiting, diarrhea, or abdominal pain were present in 117 (62%). Among patients without gastrointestinal symptoms, those who died had greater IMATI (p = 0.049), less SMI (p = 0.010), and a trend toward a greater VAT/SAT ratio. Among patients with gastrointestinal symptoms, those who died had significantly greater IMATI (p = 0.025) but no differences in other measures. CONCLUSIONS: Among patients with COVID-19, those without gastrointestinal symptoms showed the expected associations between mortality and low SMI, high IMATI, and trend toward higher VAT/SAT ratio, but those with gastrointestinal symptoms did not. Future studies should explore the mechanisms for the altered disease course in patients with COVID-19 who present with gastrointestinal symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-021-07324-4. |
format | Online Article Text |
id | pubmed-8612109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-86121092021-11-26 Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms Nobel, Yael R. Su, Steven H. Anderson, Michaela R. Luk, Lyndon Small-Saunders, Jennifer L. Reyes-Soffer, Gissette Gallagher, Dympna Freedberg, Daniel E. Dig Dis Sci Original Article BACKGROUND: Patients with SARS-CoV-2 who present with gastrointestinal symptoms have a milder clinical course than those who do not. Risk factors for severe COVID-19 disease include increased adiposity and sarcopenia. AIMS: To determine whether body composition risk factors are associated with worse outcomes among patients with gastrointestinal symptoms. METHODS: This was a retrospective study of hospitalized patients with COVID-19 who underwent abdominal CT scan for clinical indications. Abdominal body composition measures including skeletal muscle index (SMI), intramuscular adipose tissue index (IMATI), visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), visceral-to-subcutaneous adipose tissue ratio (VAT/SAT ratio), and liver and spleen attenuation were collected. The association between body composition measurements and 30-day mortality was evaluated in patients with and without gastrointestinal symptoms at the time of positive SARS-CoV-2 test. RESULTS: Abdominal CT scans of 190 patients with COVID-19 were evaluated. Gastrointestinal symptoms including nausea, vomiting, diarrhea, or abdominal pain were present in 117 (62%). Among patients without gastrointestinal symptoms, those who died had greater IMATI (p = 0.049), less SMI (p = 0.010), and a trend toward a greater VAT/SAT ratio. Among patients with gastrointestinal symptoms, those who died had significantly greater IMATI (p = 0.025) but no differences in other measures. CONCLUSIONS: Among patients with COVID-19, those without gastrointestinal symptoms showed the expected associations between mortality and low SMI, high IMATI, and trend toward higher VAT/SAT ratio, but those with gastrointestinal symptoms did not. Future studies should explore the mechanisms for the altered disease course in patients with COVID-19 who present with gastrointestinal symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-021-07324-4. Springer US 2021-11-24 2022 /pmc/articles/PMC8612109/ /pubmed/34820728 http://dx.doi.org/10.1007/s10620-021-07324-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Nobel, Yael R. Su, Steven H. Anderson, Michaela R. Luk, Lyndon Small-Saunders, Jennifer L. Reyes-Soffer, Gissette Gallagher, Dympna Freedberg, Daniel E. Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title | Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title_full | Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title_fullStr | Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title_full_unstemmed | Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title_short | Relationship Between Body Composition and Death in Patients with COVID-19 Differs Based on the Presence of Gastrointestinal Symptoms |
title_sort | relationship between body composition and death in patients with covid-19 differs based on the presence of gastrointestinal symptoms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612109/ https://www.ncbi.nlm.nih.gov/pubmed/34820728 http://dx.doi.org/10.1007/s10620-021-07324-4 |
work_keys_str_mv | AT nobelyaelr relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT sustevenh relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT andersonmichaelar relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT luklyndon relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT smallsaundersjenniferl relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT reyessoffergissette relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT gallagherdympna relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms AT freedbergdaniele relationshipbetweenbodycompositionanddeathinpatientswithcovid19differsbasedonthepresenceofgastrointestinalsymptoms |